Sebastian Bauer

37PUBLICATIONS

267CO-AUTHORS

Evolutionary ecologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (37)

Sort by Publication Date:

|Jun 11, 2026

Predicting Clinical Sensitivities of PDGFRA Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment.

|Apr 09, 2026

Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor.

Marcus Renner, Małgorzata Oleś, Nagarajan Paramasivam

|Jul 29, 2025

Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz

|Jul 04, 2025

Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study.

Andrew J Wagner, William D Tap, Sebastian Bauer

|May 23, 2025

Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE.

Michael C Heinrich, Jean-Yves Blay, Hans Gelderblom

|Jan 30, 2025

Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence.

Julius Keyl, Philipp Keyl, Grégoire Montavon

Pageof 7

Frequent Collaborators

11 joint publications

Michael C Heinrich

Hans Gelderblom

Jean-Yves Blay

Robin L Jones

Johanna Falkenhorst

Suzanne George

Thomas Mühlenberg

Margaret von Mehren

Daniel Rauh

Patrick Schöffski

Frequent Collaborators

11 joint publications

Michael C Heinrich

9 joint publications

Hans Gelderblom

8 joint publications

Jean-Yves Blay

8 joint publications

Robin L Jones